Events & Insights
Articles
4 Ways to Accelerate Cell Therapy Lot Release
Reducing vein-to-vein time requires a multi-prong strategy, and modernizing lot release is critical to the effort. This article discusses how.
Events & Insights
Explore Kincell Bio’s growing collection of articles, webinars, posters, videos, and more, featuring expert insights into the rapidly evolving cell therapy landscape.
Reducing vein-to-vein time requires a multi-prong strategy, and modernizing lot release is critical to the effort. This article discusses how.
Advance your therapy with a CDMO built to support every stage of development. Kincellis combines deep cell therapy expertise, emerging mRNA capabilities,...
Combination creates a scaled U.S. advanced therapies CDMO with broader technical expertise and capabilities from early development through commercial supply. RESEARCH TRIANGLE...
Kincellis Advanced Therapies’ incoming leadership discusses how two growing cell therapy CDMOs combined forces to expand technical expertise, capabilities, and scale.
Discover how integrated analytical and process development can accelerate cell therapy development, reduce risk, and support commercialization.
Cell therapy development is defined by a fundamental tension: the pressure to move fast and the imperative to get it right. With...
Great science starts with great people. The Kincell Bio team shares what it feels like and what it means to work at...
In this featured article from Cell & Gene Therapy Review, Roger Herr, PhD, discusses common CMC pitfalls and shares practical strategies for...
While the curative potential of cell therapies is incredible, the path from a promising candidate in the lab to an approved therapy...

Talk to an expert
Leveraging our science-first expertise and right-first-time quality, partner with Kincell Bio to advance your cell therapy from concept to commercialization.
"*" indicates required fields